Novel Pyrazolo[1,5‑<i>a</i>]pyrimidines as Translocator Protein 18 kDa (TSPO) Ligands: Synthesis, <i>in Vitro</i> Biological Evaluation, [¹⁸F]-Labeling, and <i>in Vivo</i> Neuroinflammation PET Images

A series of novel pyrazolo­[1,5-a]­pyrimidines, closely related to N,N-diethyl-2-(2-(4-(2-fluoroethoxy)­phenyl)-5,7-dimethylpyrazolo­[1,5-a]­pyrimidin-3-yl)­acetamide (2, DPA-714), were synthesized and biologically in vitro evaluated for their potential to bind the translocator protein 18 kDa (TSPO), a protein today recognized as an early biomarker of neuroinflammatory processes. This series is composed of fluoroalkyl- and fluoroalkynyl- analogues, prepared from a common iodinated intermediate via Sonogashira coupling reactions. All derivatives displayed subnanomolar affinity for the TSPO (0.37 to 0.86 nM), comparable to that of 2 (0.91 nM). Two of them were radiolabeled with fluorine-18, and their biodistribution was investigated by in vitro autoradiography and positron emission tomography (PET) imaging on a rodent model of neuroinflammation. Brain uptake and local accumulation of both compounds in the AMPA-mediated lesion confirm their potential as in vivo PET-radiotracers. In particular, [18F]23 exhibited a significantly higher ipsi- to contralateral ratio at 60 min than the parent molecule [18F]2 in vivo.